Hasil Pencarian (1)
small molecule | CAS: 871700-17-3
Trametinib is an orally bioavailable mitogen-activated extracellular signal-regulated kinase 1 (MEK1) and MEK2 inhibitor.[A258298,A258293] It was first approved by the FDA in May 2013 for the treatment of melanoma.[A258298] It was later approved by Health Can…
Kategori:
Antineoplastic AgentsAntineoplastic and Immunomodulating AgentsCytochrome P-450 CYP2C8 Inhibitors
+20
Target Protein:
Dual specificity mitogen-activated protein kinase kinase 1Dual specificity mitogen-activated protein kinase kinase 2
Waktu ParuhThe estimated elimi…
Vol. DistribusiThe apparent volume…
KlirensThe apparent cleara…
Genetik
-